Exploring the role of "Brahmi" (Bocopa monnieri and Centella asiatica) in brain function and therapy

Recent Patents on Endocrine, Metabolic and Immune Drug Discovery

Volumn 5, Issue 1, 2011, Pages 33-49

  Shinomol, G K ^a   Muralidhara, ^b   Bharath, Muchukunte M S ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

Author keywords

Ayurveda; Bacopa monnieri; Brahmi; Brain; Centella asiatica; Cognitive deficits; Learning and memory; Nootropic

Indexed keywords

AGLYCONE; ALCOHOL DERIVATIVE; ALKALOID; ASIATIC ACID; ASIATICOSIDE; BACOBITACIN A; BACOBITACIN B; BACOBITACIN C; BACOBITACIN D; BACOPA MONNIERI EXTRACT; BACOSIDE A; BACOSIDE B; BECOMING; CENTELLA ASIATICA EXTRACT; CUCURBITACIN; CUCURBITACIN E; FLAVONOID; GLYCOSIDE; HERSAPONIN; JUJUBOGENIN; MONNIERASIDE I; MONNIERASIDE III; PLACEBO; PLANT GLYCOSIDE; PLANT MEDICINAL PRODUCT; PSEUDOJUJUBOGENIN; SAPONIN; SOLVENT; SUGAR; TRITERPENOID; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMNESIA; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANXIETY NEUROSIS; AQUEOUS SOLUTION; ARTICLE; ASTHMA; ATTENTION DEFICIT DISORDER; AYURVEDA; BACOPA MONNIERI; BEHAVIOR; BRAIN FUNCTION; BRONCHITIS; CARDIOVASCULAR EFFECT; CENTELLA ASIATICA; COGNITION; DEMENTIA; DNA CLEAVAGE; DRUG EFFICACY; DRUG FORMULATION; DRUG ISOLATION; DRUG PURIFICATION; ETHNOPHARMACOLOGY; HIPPOCAMPUS; HUMAN; HYPOTHYROIDISM; LEARNING; LIVER PROTECTION; MEMORY; MENTAL DEFICIENCY; NERVOUS SYSTEM; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATENT; PETIOLE; PHASE 1 CLINICAL TRIAL (TOPIC); PLANT LEAF; PLANT ROOT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOLVENT EXTRACTION;

ANIMALS; ANTI-ANXIETY AGENTS; BACOPA; BRAIN; CLINICAL TRIALS AS TOPIC; COGNITION; HUMANS; MEDICINE, AYURVEDIC; MEMORY; MEMORY DISORDERS; MOLECULAR STRUCTURE; NEUROPROTECTIVE AGENTS; NOOTROPIC AGENTS; PATENTS AS TOPIC; PLANT EXTRACTS; PLANTS, MEDICINAL; TRITERPENES;

EID: 79551641596     PISSN: 18722148     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221411794351833     Document Type: Article

References (138)

1. Kumar V. Potential medicinal plants for CNS disorders: An overview. Phytother Res 2006; 20: 1023-35.
2. Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: Potential adverse interactions with anticancer agents. J Clin Oncol 2004; 22: 2489-503.
3. Padma TV. Ayurveda. Nature 2005; 436: 86.
4. Singh RH, Narsimhamurthy K, Singh G. Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology 2008; 9: 369-74.
5. Gohil KJ, Patel JA. A review on Bacopa monneira: Current research and future prospects. Intl J Green Pharma 2010; 4: 1-9.
6. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants. Council of Scientific and Industrial Research: New Delhi 1956.
7. Russo A, Borrelli F. Bacopa monnieri, a reputed nootropic plant: An overview. Phytomedicine 2005; 12: 305-17.
8. Nadkami KM. Indian Materia Medica. Popular Prakashan Bombay, Rep.: Bombay 1986.
9. Uphof JC. The Dictionary of Economic Plants. 2nd ed. Verlag von J Cramer: New York 1968.
10. Satyavati GV, Raina MK, Sharma M. Medicinal Plants of India. Indian Council of Medical Ressearch: New Delhi 1976; Vol 1.
11. Chopa RN. Indigenous Drugs of India. 2nd ed. U.N. Dhur and Sons: India 1958.
12. Murthy PB, Raju VR, Ramakrisana T, Chakravarthy MS, Kumar KV, Kannababu S, et al. Estimation of twelve bacopa saponins in Bacopa monnieri extracts and formulations by high-performance liquid chromatography. Chem Pharm Bull (Tokyo) 2006; 54: 907-11.
13. Deepak M, Amit A. The need for establishing identities of bacoside A and B, the putative major bioactive saponins of Indian medicinal plant Bacopa monnieri. Phytomedicine 2004; 11: 264-8.
14. Deepak M, Sangli GK, Arun PC, Amit A. Quantitative determination of the major saponin mixture bacoside A in Bacopa monnieri by HPLC. Phytochem Anal 2005; 16: 24-9.
15. Sivaramakrishna C, Rao CV, Trimurtulu G, Vanisree M, Subbaraju GV. Triterpenoid glycosides from Bacopa monnieri. Phytochemistry 2005; 66: 2719-28.
16. Bhandari P, Kumar N, Singh B, Kaul VK. Cucurbitacins from Bacopa monnieri. Phytochemistry 2007; 68: 1248-54.
17. Hou CC, Lin SJ, Cheng JT, Hsu FL. Bacopaside III, bacopasaponin G and bacopasides A, B, C, from Bacopa monnieri. J Nat Prod 2002; 65: 1759-63.
18. Chakravarty AK, Garai S, Masuda K, Nakane T, Kawahara N. Bacopasides III-V: Three new triterpenoid glycosides from Bacopa monnieri. Chem Pharm Bull 2003; 51: 215-7.
19. Rastogi S, Pal R, Kulshreshtha DK. Bacoside A3-A triterpenoid saponin from Bacopa monnieri. Phytochemistry 1994; 36: 133-7.
20. Chakravarty AK, Sarkar T, Masuda K, Shiojima K, Nakane T, Kawahara N. Bacopaside I and II: Two pseudojujubogenins glycosides from Bacopa monnieri. Phytochemistry 2001; 58: 553-6.
21. Higuchi R, Kubota S, Komori T, Kawasaki T, Pandey VB, Singh JP, et al. Triterpenoid saponins from the bark of Zizyphus joazeiro. Phytochemistry 1984; 23: 2597-600.
22. Garai S, Mahato SB, Ohtani K, Yamasaki K. Dammarane-type triterpenoid saponins from Bacopa monnieri. Phytochemistry 1996; 42: 815-20.
23. Mahato SB, Garai S, Chakravarty AK. Bacopasaponins E and F: Two jujubogenin bisdesmosides from Bacopa monnieri. Phytochemistry 2000; 53: 711-4.
24. Dhanasekaran M, Tharakan B, Holcomb LA, Hitt AR, Young KA, Manyam BV. Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monnieri. Phytother Res 2007; 21: 965-9.
25. Sberna G, Saez-Valero J, Beyreuther K, Masters CL, Small DH. The amyloid beta-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells. J Neurochem 1997; 69: 1177-84.
26. Limpeanchob N, Jaipan S, Rattanakaruna S, Phrompittayarat W, Ingkaninan K. Neuroprotective effect of Bacopa monnieri on betaamyloid- induced cell death in primary cortical culture. J Ethnopharmacol 2008; 120: 112-7.
27. Russo A, Izzo AA, Borrelli F, Renis M, Vanella A. Free radical scavenging capacity and protective effect on DNA damage of Bacopa monnieri. Phytother Res 2003; 17: 870-5.
28. Russo A, Borrelli F, Campisi A, Acquaviva R, Raciti G, Vanella A. Nitric oxide-related toxicity in cultured astrocytes: effect of Bacopa monnieri. Life Sci 2003; 73: 1517-26.
29. Bhattacharya SK, Bhattacharya A, Kumar A, Ghosal S. Antioxidant activity of Bacopa monnieri in rat frontal cortex, striatum and hippocampus. Phytother Res 2000; 14: 174-9.
30. Tripathi YB, Chaurasia S, Tripathi E, Upadhyay A, Dubey GP. Bacopa monnieri Linn. as an antioxidant: Mechanism of action. Indian J Exp Biol 1996; 34: 523-6.
31. Sumathy TS, Govindasamy S, Balakrishna K, Veluchamy G. Protective role of Bacopa monnieri on morphine-induced brain mitochondrial enzyme activity in rats. Fitoterapia 2002; 73: 381-5.
32. Hosamani R, Muralidhara. Prophylactic treatment with Bacopa monnieri leaf powder mitigates paraquat-induced oxidative perturbations and lethality in Drosophila melanogaster. Indian J Biochem Biophys 2010; 47: 75-82.
33. Hosamani R, Muralidhara. Neuroprotective efficacy of Bacopa monnieri against rotenone induced oxidative stress and neurotoxicity in Drosophila melanogaster. Neurotoxicology 2009; 30: 977-85.
34. Shinomol GK, Muralidhara. Bacopa monnieri modulates endogenous cytoplasmic and mitochondrial oxidative markers in prepubertal mice brain. Phytomedicine 2010 (in press).
35. Anbarasi K, Vani G, Balakrishna K, Desai CS. Creatine kinase isoenzyme patterns upon chronic exposure to cigarette smoke: Protective effect of Bacoside A. Vascul Pharmacol 2005; 42: 57-61.
36. Anbarasi K, Kathirvel G, Vani G, Jayaraman G, Devi SCS. Cigarette smoking induces heat shock protein 70kDa expression and apoptosis in rat brain: Modulation by bacoside A. Neuroscience 2006; 138: 1127-35.
37. Chowdhuri DK, Parmar D, Kakkar P, Shukla R, Seth PK, Srimal RC. Antistress effects of bacosides of Bacopa monnieri: Modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain. Phytother Res 2002; 16: 639-45.
38. Mills S, Bone K. Principles and Practice of Phytotherapy. Harcourt Publishers Ltd: London 2000.
39. Blumenthal ME. The American Botanical Council (ABC) Clinical Guide to Herbs. The American Botanical Council: Texas 2003.
40. Sheikh N, Ahmada A, Siripurapu KA, Kuchibhotla VK, Singh S, Palit G. Effect of Bacopa monnieri on stress induced changes in plasma corticosterone and brain monoamines in rats. J Ethnopharmacol 2007; 111: 671-6.
41. Jyoti A, Sethi P, Sharma D. Bacopa monnieri prevents from aluminium neurotoxicity in the cerebral cortex of rat brain. J Ethnopharmacol 2007; 111: 56-62.
42. Kapoor R, Srivastava S, Kakkar P. Bacopa monnieri modulates antioxidant responses in brain and kidney of diabetic rats. Environ Toxicol Pharmacol 2009; 27: 62-9.
43. Saraf MK, Prabhakar S, Anand A. Neuroprotective effect of Bacopa monnieri on ischemia induced brain injury. Pharmacol Biochem Behav 2010; 97:192-7.
44. Malhotra CL, Das PK. Pharmacological studies on Herpestis monnieri (Brahmi). Indian J Med Res 1969; 47: 294-305.
45. Singh HK, Dhawan BN. Effect of Bacopa monnieri Linn. (Brahmi) extract on avoidance responses in rat. J Ethnopharmacol 1982; 5: 205-14.
46. Singh HK, Dhawan BN. Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monnieri Linn. (Brahmi). Indian J Pharmacol 1997; 29: 359-65.
47. Kishore K, Singh M. Effect of bacosides, alcoholic extract of Bacopa monnieri Linn. (Brahmi), on experimental amnesia in mice. Indian J Exp Biol 2005; 43: 640-5.
48. Vollala VR, Upadhya S, Nayak S. Effect of Bacopa monnieri Linn. (brahmi) extract on learning and memory in rats: A behavioral study. J Vet Behav: Clin Appl Res 2010; 5: 69-74.
49. Saraf K, Prabhakar S, Pandhib P, Ananda A. Bacopa monnieri ameliorates amnesic effects of diazepam qualifying behavioralmolecular partitioning. Neuroscience 155; 2008: 476-84.
50. Khan R, Krishnakumar A, Paulose CS. Decreased glutamate receptor binding and NMDA R1 gene expression in hippocampus of pilocarpine-induced epileptic rats: Neuroprotective role of Bacopa monnieri extract. Epilepsy Behav 2008; 12: 54-60.
51. Krishnakumar A, Nandhu MS, Paulose CS. Upregulation of 5- HT2C receptors in hippocampus of pilocarpine-induced epileptic rats: Antagonism by Bacopa monnieri. Epilepsy Behav 2009; 16: 225-30.
52. Das A, Shanker G, Nath C, Pal R, Singh S, Singh H. A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba: Anticholinesterase and cognitive enhancing activities. Pharmacol Biochem Behav 2002; 73: 893-900.
53. Rai D, Bhatia G, Palit G, Pal R, Singh S, Singh HK. Adaptogenic effect of Bacopa monnieri (Brahmi). Pharmacol Biochem Behav 2003; 75: 823-30.
54. Bhattacharya SK, Ghosal S. Anxiolytic activity of a standardized extract of Bacopa monnieri - An experimental study. Phytomedicine 1998; 5: 77-82.
55. Stough C, Lloyd J, Clarke J, Downey AL, Hutchison CW, Rodgers T, et al. The chronic effects of an extract of Bacopa monnieri (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology 2001; 156: 481-4.
56. Bhattacharya SK, Kumar A, Ghosal S. In: Sankar SDV, Ed. Effect of Bacopa monnieri on Animal Models of Alzheimer's disease and Perturbed Central Cholinergic Markers of Cognition in Rats. Molecular Aspects of Asian Medicines. New York: PJD Publications 1999: 27-58.
57. Sara SJ. Noradrenergic-cholinergic interaction: Its possible role in memory dysfunction associated with senile dementia. Arch Gerontol Geriatr 1989; 1: 99-108.
58. Kidd PM. A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Altern Med Rev 1999; 4: 144-61.
59. Pravina K, Ravindra KR, Goudar KS, Vinod DR, Joshua AJ, Wasim P, et al. Safety evaluation of BacoMind in healthy volunteers: A phase I study. Phytomedicine 2007; 14: 301-8.
60. Sumathy T, Subramanian S, Govindasamy S, Balakrishna K, Veluchamy G. Protective effect of Bacopa monnieri on morphine induced hepatotoxicity in rats. Phytother Res 2001; 15: 643-5.
61. Channa S, Dar A, Yaqoob SAM, Atta-ur-Rahman. Anti-inflammatory activity of Bacopa monnieri in rodents. J Ethnopharmacol 2006; 104: 286-9.
62. Rao CV, Sairam K, Goel RK. Experimental evaluation of Bocopa monnieri on rat gastric ulceration and secretion. Indian J Physiol Pharmacol 2000; 44: 435-41.
63. Goel RK, Sairam K, Babu MD, Tavares IA, Raman A. in vitro Evaluation of Bacopa monnieri on anti-Helicobacter pylori activity and accumulation of prostaglandins. Phytomedicine 2003; 10: 523-7.
64. Yadav SK, Jain AK, Tripathi SN, Gupta JP. Irritable bowel syndrome: Therapeutic evaluation of indigenous drugs. Indian J Med Res 1989; 90: 496-503.
65. Janani P, Sivakumari K, Geetha A, Ravisankar B, Parthasarathy C. Chemopreventive effect of bacoside A on N-nitrosodiethylamineinduced hepatocarcinogenesis in rats. J Cancer Res Clin Oncol 2010; 136: 759-70.
66. Peng L, Zhou Y, Kong de Y, Zhang WD. Antitumor activities of dammarane triterpene saponins from Bacopa monnieri. Phytother Res 2010; 24: 864-8.
67. Dar A, Channa S. Calcium antagonistic activity of Bacopa monnieri on vascular and intestinal smooth muscles of rabbit and guinea-pig. J Ethnopharmacol 1999; 66: 167-74.
68. Channa S, Dar A, Yaqoob M, Anjum S, Sultani Z, Atta-ur-Rahman. Broncho-vasodilatory activity of fractions and pure constituents isolated from Bacopa monnieri. J Ethnopharmacol 2003; 86: 27-35.
69. Samiulla DS, Prashanth D, Amit A. Mast cell stabilising activity of Bacopa monnieri. Fitoterapia 2001; 72: 284-5.
70. Martis G, Rao A. Neuropharmacological activity of Herpestis monnieri. Fitoterapia 1992; 63: 399-404.
71. Kar A, Panda S, Bharti S. Relative efficacy of three medicinal plant extracts in the alteration of thyroid hormone concentrations in male mice. J Ethnopharmacol 2002; 81: 281-5.
72. Badmaev V. Bacopin (Bacopa monnieri): A Memory Enhancer from Ayurveda. Sabinsa Corporation: New Jersey 1998.
73. Shukia B, Khanna NK, Godhwani JL. Effect of Brahmi Rasayan on the central nervous system. J Ethnopharmacol 1987; 21: 65-74.
74. Dave UP, Chauvan V, Dalvi J. Evaluation of BR-16 A (Mentat) in cognitive and behavioral dysfunction of mentally retarded children: A placebo-controlled study. Indian J Pediatr 1993; 60: 423-8.
75. Sharma R, Chaturvedi C, Tewari PV. Efficacy of Bacopa monnieri in revitalizing intellectual functions in children. Indian J Med Res 1987; 6: 1-10.
76. Negi KS, Singh YD, Kushwaha KP, Rastogi CK, Rathi AK, Srivastava JS. Clinical evaluation of memory enhancing properties of Memory Plus in children with attention deficit hyperactivity disorder. Indian J Psychiatry 2000; 42: 42-50.
77. Roodenrys S, Booth D, Bulzoni S, Phipps A, Micallef C, Smoker J. Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology 2002; 27: 279-81.
78. Singh RH, Singh L. Studies on the anti-anxiety effect of the medhya rasayana drug, Brahmi (Bacopa monnieri Wettst.)- Part 1. J Res Ayurveda Siddha 1980; 1: 133-48.
79. Nathan PJ, Clarke J, Lloyd J, Hutchison CW, Downey L, Stough C. The acute effects of an extract of Bacopa monnieri (Brahmi) on cognitive function in healthy normal subjects. Hum Psychopharmacol 2001; 16: 345-51.
80. Maher BF, Stough C, Shelmerdine A, Wesnes K, Nathan PJ. The acute effects of combined administration of Ginkgo biloba and Bacopa monnieri on cognitive function in humans. Hum Psychopharmacol 2002; 17: 163-4.
81. Kartnig T. Clinical application of Centella asiatica (L.) Urb. In: Craker LE, Simon JE, Eds. Herbs, Spices and Medicinal Plants. Phoenix: Oxyx Press 1988: 145-73.
82. Viala A, Cano JP, Duranid A, Paulin R, Roux F, Placici M, et al. Study in animals of transcutaneous penetration of labeled active principles of the titrated extract of Centella asiatica applied on the skin in two topical forms. Therapie 1977; 32: 573-84.
83. Shukla A, Racik AM, Jain GK, Shankar R, Kulshrestha DK, Dhawan BN. in vitro and in vivo Wound healing activity of asiaticoside isolated from Centella asiatica. J Ethnopharmacol 1999; 65: 1-11.
84. Chatterjee TK, Chakarbotty A, Pathak M. Effect of plant extract Centella asiatica (Linn.) on cold restraint stress ulcer in rats. Indian J Exp Biol 1992; 30: 889-91.
85. Suguna L, Sivakumar P, Chandrakasan G. Effects of Centella asiatica extract on dermal wound healing in rats. Indian J Exp Biol 1996; 34: 1208-11.
86. Babu TD, Kuttan G, Padikkala J. Cytotoxic and antitumour properties of certain taxa of Umbelliferae with special reference to Centella asiatica (L.) Urban. J Ethnopharmacol 1995; 48: 53-7.
87. Veechai AD, Senmi J, Gassan G, Mohinaro M. Effect of Centella asiatica on the biosynthetic activity of fibroblast in culture. Farmacie Ed 1984; 39: 355-64.
88. Mukerji B. Indian Pharmaceutical Codex. Indigenous drugs. Council of Scientific and Industrial Research: New Delhi 1953;1.
89. Vaidyaratnam PSV. Indian Medicinal Plants: A Compendium of 500 Species. Orient Longman Ltd.: Madras 1994; 2.
90. Apparao MVR, Srinivasan K, Rao K. Effect of Mandookaparni (Centella asiatica) on the general mental ability (Medhya) of mentally retarded children. J Res Ind Med 1973; 8: 9-16.
91. Haleagrahara N, Ponnusamy K. Neuroprotective effect of Centella asiatica extract (CAE) on experimentally induced parkinsonism in aged Sprague-Dawley rats. J Toxicol Sci 2010; 35: 41-7.
92. Gupta R, Flora SJ. Effect of Centella asiatica on arsenic induced oxidative stress and mental distribution in rats. J Appl Toxicol 2006; 26: 213-22.
93. Guo JS, Cheng CL, Koo MW. Inhibitory effects of Centella asiatica water extract and asiaticoside on inducible nitric oxide synthase during gastric ulcer healing in rats. Planta Med 2004; 70: 1150-4.
94. Punuree K, Wild CP, Kasinrerk W, Vinitketkumnuen U. Immunodulatory activities of Centella asiatica and Rhimachanthus nasutus extracts. Asian Pac J Can Prev 2005; 6: 396-400.
95. Yoshida M, Fuchigami M, Nago T, Okabe H, Matsunaga K, Takata J, et al. Antiproliferative constituents from umbelliferae plants VII. Active triterpene and rosmarinic acid from Centella asiatica. Biol Pharm Bull 2005; 28: 173-5.
96. Sharma J, Sharma R. Radioprotection of Swiss albino mouse by Centella asiatica extract. Phytother Res 2002; 16: 785-6.
97. Siddique YH, Ara G, Beg T, Faisal M, Ahmad M, Afzal M. Antigenotoxic role of Centella asiatica L. extract against cyproterone acetate induced genotoxic damage in cultured human lymphocytes. Toxicol In Vitro 2008; 22: 10-7.
98. De Sanctis MT, Belcaro G, Incandela L, Cesarone MR, Griffin M, Ippolito E, et al. Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: A clinical, prospective, placebo-controlled, randomized, dose-ranging Trial. Angiology 2001; 52: S53-S9.
99. Incandela L, Belcaro G, Nicolaides AN, Cesarone MR, De Sanctis MT, Corsi M, et al. Modification of the echogenicity of femoral plaques after treatment with total triterpenic fraction of Centella asiatica: A prospective, randomized placebo-controlled trail. Angiology 2001; 52: S69-S73.
100. Katare SS, Ganachari MS. Effect of Centella asiatica on hypoxia induced convulsions and lithium-pilocarpine induced status epilepticus and anti lipidperoxidation activity. Indian J Pharmacol 2001; 33: 128.
101. Jayashree G, Kurup MG, Sudarslal VS, Jacob VB. Anti-oxidant activity of Centella asiatica on lymphoma-bearing mice. Fitoterapia 2003; 74: 431-4.
102. Zainol MK, Abd-Hamid A, Yusof S, Muse R. Antioxidant activity and total phenolic compounds of leaf, root and petiole of four accessions of Centella asiatica (L) Urban. Food Chem 2003; 81: 575-81.
103. Inamdar PK, Yeole RD, Ghogare AB, de Souza NJ. Determination of biologically active constituents in Centella asiatica. J Chromatogr A 1996; 742: 127-30.
104. Mook-Jung I, Shin JE, Yun SH, Huh K, Koh JY, Park HK, et al. Protective effects of asiaticoside derivatives against beta-amyloid neurotoxicity. J Neurosci Res 1999; 58: 417-25.
105. Wijeweeraa P, Arnasona JT, Koszyckib D, Merali Z. Evaluation of anxiolytic properties of Gotukola - (Centella asiatica) extracts and asiaticoside in rat behavioral models. Phytomedicine 2006; 13: 668-76.
106. Sakina MR, Dandiya PC. A psychopharmacological profile of Centella asiatica extract. Fitoterapia 1990; 61: 291-6.
107. Lucia RD, Sertie JAA, Camargo EA, Panizza S. Pharmacological and toxicological studies on Centella asiatica. Fitoterapia 1997; 68: 413-6.
108. Subathra M, Shila S, Devi SM, Panneerselvam C. Emerging role of Centella asiatica in improving age-related neurological antioxidant status. Exp Gerontol 2005; 40: 707-15.
109. Gupta YK, Kumar VMH, Srivastava AK. Effect of Centella asiatica on pentylenetetrazole-induced kindling, cognition and oxidative stress in rats. Pharmacol Biochem Behav 2003; 74: 579-85.
110. Rao SB, Chetana M, Devi UP. Centella asiatica treatment during postnatal period enhances learning and memory in mice. Physiol Behav 2005; 86: 449-57.
111. Shinomol GKM. Prophylactic neuroprotective property of Centella asiatica against 3-nitropropionic acid induced oxidative stress and mitochondrial dysfunctions in brain regions of prepubertal mice. Neurotoxicology 2008; 29: 948-57.
112. Shinomol GK, Muralidhara. Effect of Centella asiatica leaf powder on oxidative markers in brain regions of prepubertal mice in vivo and its in vitro efficacy to ameliorate 3-NPA-induced oxidative stress in mitochondria. Phytomedicine 2008; 15: 971-84.
113. Shinomol GK, Ravikumar H, Muralidhara. Prophylaxis with Centella asiatica confers protection to prepubertal mice against 3- nitropropionic-acid-induced oxidative stress in brain. Phytother Res 2010; 24: 885-92.
114. Barbosa NR, Pittella F, Gattaz WF. Centella asiatica water extract inhibits iPLA2 and cPLA2 activities in rat cerebellum Phytomedicine 2008; 17: 896-900.
115. Nalini K, Arroor AR, Karanth KS, Rao A. Effect of Centella asiatica fresh leaf aqueous extract on learning and memory and biogenic amine turnover in albino rats. Fitoterapia 1992; 63: 232-7.
116. Kumar VMH, Gupta YK. Effect of different extracts of Centella asiatica on cognition and markers of oxidative stress in rats. J Ethnopharmacol 2002; 79: 253-60.
117. Kuppurajan K, Srinivasan K, Janaki K. A double blind study of the effect of Mandukaparni on the general mental ability of normal children. J Res Indian Med Yoga Homoeo 1978; 13: 37-41.
118. Bradwejn J, Zhou Y, Koszycki D, Shlik J. A double-blind, placebocontrolled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects. J Clin Psychopharmacol 2000; 20: 680-4.
119. Wattanathorn J, Mator L, Muchimapura S, Tongun T, Pasuriwong O, Piyawatkul N, et al. Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of Centella asiatica. J Ethnopharmacol 2008; 116: 325-32.
120. Abdul-Hamid A, Md. Shaha Z, Museb R, Mohameda S. Characterization of antioxidative activities of various extracts of Centella asiatica (L) Urban. Food Chem 2002; 77: 465-9.
121. Bunpo PK, Kataoka H, Arimochi H, Nakayama T, Kuwahara Y, Bando K, et al. Inhibitory effects of Centella asiatica on azoxymethane-induced aberrant crypt focus formation and carcinogenesis in the intestines of F344 rats. Food Chem Toxicol 2004; 42: 1987-97.
122. Gnanapragasam AK, Ebenezara KV, Sathisha P, Govindaraju, Devaki T. Protective effect of Centella asiatica on antioxidant tissue defense system against adriamycin induced cardiomyopathy in rats. Life Sci 2004; 76: 585-97.
123. Cheng CL, Koo MWL. Effects of Centella asiatica on ethanol induced gastric mucosal lesions in rats. Life Sci 2000; 67: 2647-53.
124. Cheng CL, Guoa JS, Lukb J, Koo MWL. The healing effects of Centella extract and asiaticoside on acetic acid induced gastric ulcers in rats. Life Sci 2004; 74: 2237-49.
125. Hussin AM, Abdul-Hamid, Suhaila M, Nazamid S, Maznah I, Bejo MH. Protective effect of Centella asiatica extract and powder n oxidative stress in rats. Food Chem 2007; 100: 535-41.
126. Wang XS, Dong Q, Zuo JP, Fang JN. Structure and potential immunological activity of a pectin from Centella asiatica (L.) Urban. Carbohydr Res 2003; 338: 2393-402.
127. Kahol, A.P., Singh, T., Tandon, S., Gupta, M.M., Khanuja, S.P. Process for the preparation of a extract rich in bacosides from the herb Bacopa monnieri. US6833143 (2004).
128. Gokaraju, G.R., Gokaraju, R.R., Gottumukala, V.S., Golakoti, T., Chillara, S. Process for producing enriched fractions containing up to 100% of Bacopasaponins from the plant materials of Bacopa species. US20080132455 (2008).
129. Agarwal, A. Synergistic herbal composition from Bacopa species for management of neurodegenerative disorders and a process of preparation thereof. US20090192097 (2009).
130. Prasad, D.G. Herbal preparation for management of cardiovascular and neurologic disorders. US7273626 (2007).
131. Prasad, D.G. Herbal preparation for management of cardiovascular and neurologic disorders. US20060034950 (2006).
132. Pandita, M.K., Dubey, G.P. Composition for improving mental capabilities in mammals. US20030157201 (2003).
133. Smith, K.L. Compositions for improving mental performance. US20050244510 (2005).
134. Lin, C.H., Chih, H. Herbal composition for preventing and/or treating conditions associated with depression. US20040180104 (2004).
135. Castillo, G., Snow, A.D., Desantis, D.A. Compositions for treating Alzheimer's disease and other amyloidoses. US6264994 (2001).
136. Stock, J.B., Stock, M., Haoming, G., Stock, G.B., Li, Z., Wolanin, P.M. Compositions and methods for enhancing cognitive function. US 20060171938 (2006).
137. Myhill, P.R., Driscoll, W.J. Compositions for alleviating inflammation and oxidative stress in a mammal. US20090311350 (2009).
138. Myhill, P.R., Driscoll, W.J. Methods for enhancing antioxidant enzyme activity and reducing C-reactive protein levels. US7579026 (2009).